Navigation Links
New breast cancer risk model quantifies the impact of risk reduction
Date:6/24/2011

How much can a woman lower her risk of breast cancer by losing weight, drinking less, or exercising more? A study published online June 24 in the Journal of the National Cancer Institute describes a new model to estimate the impact of these lifestyle changes on absolute breast cancer risk, suggesting risk reductions that could translate into a substantial number of prevented cancers across an entire population.

Breast cancer risk models are widely used to estimate a woman's chances of developing the disease. These are based on non-modifiable risk factors such as age and family history of breast cancer and on modifiable lifestyle factors. But there is little information on how much lifestyle changes would reduce absolute breast cancer risk in individuals and in the population.

In this study, Elisabetta Petracci, Ph.D., and Mitchell Gail, M.D., Ph.D., at the National Cancer Institute and colleagues developed the model using data from an Italian case-control study with more than 5,000 women. Their model includes five risk factors that are difficult or impossible to modify (reproductive characteristics, education, occupational activity, family history, and biopsy history) and three risk factors that are more modifiable (alcohol consumption, leisure physical activity, and body mass index).

The model predicted that changes in the more modifiable risk factors would reduce the absolute risk of developing breast cancer by quantifiable amounts. The average 20-year reduction in absolute risk among women aged 65 was 1.6% in the entire population; 3.2% among women with a positive family history of breast cancer; and 4.1% among women with the most non-modifiable risk factors.

The authors note that the results may help in designing programs aimed at encouraging lifestyle changes. For instance, in a general population of 1 million women, even a 1.6% absolute risk reduction amounts to 16,000 fewer cases of cancer. In contrast, a 3.2% reduction in a higher-risk group--postmenopausal women with a family history--amounts to only 2,560 fewer cases, according to the model.

The authors conclude that these results give perspective on the potential public health impact of reducing exposure to such risk factors and could be useful for designing studies to test the efficacy of prevention programs.

In an accompanying editorial, Kathy J. Helzlsouer, M.D., of Mercy Medical Center in Baltimore writes that the study "provides extremely important information relevant to counseling women on how much risk reduction they can expect by changing behaviors, and also highlights the basic public health concept that small changes in individual risk can translate into a meaningful reduction in disease in a large population." However, she also points out that these estimates are based on optimistic assumptions of changes in behaviors and that the results do not necessarily apply to people in other countries, such as the U.S., where breast cancer rates among older women are much higher than in Italy.

"These differences, however, serve to emphasize the need for models such as these to be created on the basis of local data to provide the best estimates of risk to aid decision making, whether for the individual or the population in public health settings," she writes.


'/>"/>

Contact: Caroline McNeil
caroline.mcneil@oup.com
301-841-1286
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
2. Low forms of cyclin E reduce breast cancer drugs effectiveness
3. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
4. For Some Breast Cancer Patients, Shorter Radiation Works Well
5. Short-term radiation therapy successful on breast cancer
6. Few Women at High Risk for Breast Cancer Take Tamoxifen
7. Hormone May Prevent Aggressive Breast Cancer
8. MSU researcher linking breast cancer patients with alternative therapies
9. MRI May Not Add Value to Routine Breast Cancer Care
10. Breast Cancer Stats Differ Racially Despite Similar Mammogram Rates
11. Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates Fight Against Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... , ... Harbour , a DAO (decentralized autonomous organization) that harnesses the ... their technical specifications . , 2017 has seen an explosion of token launches ... which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of Harbour, ...
(Date:6/27/2017)... , ... June 27, 2017 , ... A January 18th ... projected to reach a staggering $6.81 billion by the year 2024 according to a ... a faster rate than those made from titanium. Los Angeles area clinic Beverly Hills ...
(Date:6/27/2017)... ... June 27, 2017 , ... Drs. Gregory Toback and ... in Mystic, CT. Covering the process and maintenance strategies of gum grafting and ... periodontal procedures. Drs. Toback and Urbanski practice as experienced periodontists in ...
(Date:6/27/2017)... Los Angeles, CA (PRWEB) , ... June 27, 2017 , ... ... on what crooked bites can indicate about early life experiences. What happens to a ... study reveals that stresses after birth can also take a toll on a baby’s ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for Advanced Orthopaedics ... of Richard Robinson as chief operating officer (COO). In this role, Robinson brings ... track record of simplifying business processes and developing growth strategies to increase market ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... 3, 2017  Eli Lilly and Company (NYSE: ... from the Phase 3 MONARCH 2 study showed ... inhibitor, in combination with fulvestrant, significantly improved progression-free ... in women with hormone-receptor-positive (HR+), human epidermal growth ... have relapsed or progressed after endocrine therapy (median ...
Breaking Medicine Technology: